Shawn Cross

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Washington, DC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kristen Williams, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Shawn Cross

Form 4 holding Director

Cyclo Therapeutics, Inc.

Security class
Common Stock
Shares / value
136,346
Estimated value
$85,898
Report date
27 Feb 2025
Price
$0.6300
Ownership
Direct
Form 4 holding Chief Financial Officer

Pacira BioSciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
150,000
Estimated value
Report date
23 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cyclo Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,562
Estimated value
Report date
03 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO & Chair of the Board, Director

Applied Molecular Transport Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
27 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Shawn Cross

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .